Microalbuminuria and hypertension in pregnancy: Role of aldosterone and inflammation

Journal of Clinical Hypertension

Volumn 15, Issue 9, 2013, Pages 612-614

  Armanini, Decio ^a   Ambrosini, Guido ^a   Sabbadin, Chiara ^a   Donà, Gabriella ^a   Clari, Giulio ^a   Bordin, Luciana ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ALDOSTERONE ANTAGONIST; ANTIOXIDANT; CANRENONE; CYTOKINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EPLERENONE; GROWTH FACTOR; REACTIVE OXYGEN METABOLITE; RENIN; SCAVENGER; SPIRONOLACTONE;

ANGIOGENESIS; CARDIOVASCULAR RISK; CYTOKINE RELEASE; DIABETIC NEPHROPATHY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE MARKER; HORMONAL REGULATION; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; INFLAMMATION; INSULIN RESISTANCE; KIDNEY DYSFUNCTION; KIDNEY INJURY; LEUKOCYTE; MATERNAL HYPERTENSION; MENSTRUATION; MICROALBUMINURIA; NOTE; OXIDATIVE STRESS; PLACENTA DISORDER; PLACENTA PERFUSION; PREECLAMPSIA; PREGNANCY; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL; RISK FACTOR; RISK REDUCTION; T LYMPHOCYTE;

AGING; ALBUMINURIA; FEMALE; HUMANS; HYPERTENSION; PREGNANCY; PREGNANCY COMPLICATIONS;

EID: 84883461639     PISSN: 15246175     EISSN: 17517176     Source Type: Journal    
DOI: 10.1111/jch.12135     Document Type: Note

References (20)

1. Kattah AG, Asad R, Scantlebury DC, et al. Hypertension in pregnancy is a risk factor for microalbuminuria later in life. J Clin Hypertens (Greenwich). 2013; DOI: 10.1111/jch.12116.
2. Ganie MA, Farooqui KJ, Bhat MA, et al. Pattern of urinary albumin excretion in normotensive young and adolescent Indian women with polycystic ovary syndrome. Indian J Endocrinol Metab. 2012;16:277-282.
3. Veltman-Verhulst SM, van Rijn BB, Westerveld HE, et al. Polycystic ovary syndrome and early-onset preeclampsia: reproductive manifestations of increased cardiovascular risk. Menopause. 2010;17:990-996.
4. Duka I, Bakris G. Influence of microalbuminuria in achieving blood pressure goals. Curr Opin Nephrol Hypertens. 2008;17:457-463.
5. Armanini D, Karbowiak I, Goi A, et al. In-vivo metabolites of spironolactone and potassium canrenoate: determination of potential anti-androgenic activity by a mouse kidney cytosol receptor assay. Clin Endocrinol (Oxf). 1985a;23:341-347.
6. Funder JW. Eplerenone: hypertension, heart failure and the importance of mineralocorticoid receptor blockade. Future Cardiol. 2006;2:535-541.
7. Halimi JM, Mimran A. Albuminuria in untreated patients with primary aldosteronism or essential hypertension. J Hypertens. 1995;13:1801-1802.
8. Borzychowski AM, Sargent IL, Redman CW. Inflammation and pre-eclampsia. Semin Fetal Neonatal Med. 2006;11:309-316.
9. Armanini D. Preeclampsia: the role of aldosterone in hypertension and inflammation. Hypertension. 2012;59:1099-1100.
10. + T cells in healthy pregnancy but not in preeclampsia. J Immunol. 2009;183:7023-7030.
11. Pitt B. Effect of aldosterone blockade in patients with systolic left ventricular dysfunction implications of the RALES and EPHESUS studies. Mol Cell Endocrinol. 2004;217:53-58.
12. Armanini D, Strasser T, Weber PC. Characterization of aldosterone binding sites in circulating human mononuclear leukocytes. Am J Physiol. 1985b;248(3 Pt 1):E388-E390.
13. Armanini D, Endres S, Kuhnle U, Weber PC. Parallel determination of mineralocorticoid and glucocorticoid receptors in T- and B-lymphocytes of human spleen. Acta Endocrinol (Copenh). 1988;118:479-482.
14. Wehling M, Kuhls S, Armanini D. Volume regulation of human lymphocytes by aldosterone in isotonic media. Am J Physiol. 1989;257(2 Pt 1):E170-E174.
15. Armanini D, Zennaro CM, Martella L, et al. Mineralocorticoid effector mechanism in preeclampsia. J Clin Endocrinol Metab. 1992;74:946-949.
16. Calò LA, Zaghetto F, Pagnin E, et al. Effect of aldosterone and glycyrrhetinic acid on the protein expression of PAI-1 and p22(phox) in human mononuclear leukocytes. J Clin Endocrinol Metab. 2004;89:1973-1976.
17. Herrada AA, Contreras FJ, Marini NP, et al. Aldosterone promotes autoimmune damage by enhancing Th17-mediated immunity. J Immunol. 2010;184:191-202.
18. Macdonald-Wallis C, Lawlor DA, Fraser A, et al. Blood pressure change in normotensive, gestational hypertensive, preeclamptic, and essential hypertensive pregnancies. Hypertension. 2012;59:1241-1248.
19. Armanini D, Bordin L, Donà G, et al. Polycystic ovary syndrome: implications of measurement of plasma aldosterone, renin activity and progesterone. Steroids. 2012;77:655-658.
20. Monster TB, Janssen WM, de Jong PE, de Jong-van den Berg LT. Prevention of Renal and Vascular End Stage Disease Study Group. Oral contraceptive use and hormone replacement therapy are associated with microalbuminuria. Arch Intern Med. 2001;161:2000-2005.